Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT07008664
Official study title

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

Study summary

The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedEpigenetic Signature Assay

The study team can explain what participation involves.

Who it may be forLung Cancer · Lung Cancer Screening

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 29, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Maryland, Baltimore

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Maryland, Baltimore
Interventions being studied
Other: Epigenetic Signature Assay
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 18 years old or older
  • Patient at University of Maryland Baltimore Washington Medical Center
  • Willing and able to consent to study procedures listed in the protocol
  • Ability to speak and understand English
Reasons someone may not be able to joinExclusion criteria
  • Younger than 18 years old
  • Patient not cared for at University of Maryland Baltimore Washington Medical Center
  • Unable to consent to study procedures listed in the protocol
  • Unable to speak or understand English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Maryland Baltimore Washington Medical CenterGlen Burnie, Maryland

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 29, 2026. Always confirm current availability with the study team.

View original record ↗